Advanced in Ascher Syndrome

Laurence Verneuil

UMR-1153, 1 Avenue Claude Vellefaux, 
Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Ascher Syndrome
UMR-1153, 1 Avenue Claude Vellefaux, 
Paris, FR 
OverviewLocationsClinical Research

Overview

Laurence Verneuil practices in Paris, France. Mr. Verneuil is rated as an Advanced expert by MediFind in the treatment of Ascher Syndrome. His top areas of expertise are Ascher Syndrome, Triple-Negative Breast Cancer, Anorexia, Cutaneous T-Cell Lymphoma (CTCL), and Kidney Transplant.

His clinical research consists of co-authoring 78 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Ascher Syndrome.

Gender
Male

Locations

UMR-1153, 1 Avenue Claude Vellefaux, Paris, 75010, France
Other Locations
Nantes, France
Caen, France
Basseux, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Enrollment Status: Recruiting
Publish Date: February 11, 2025
Intervention Type: Other
Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment
Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment
Enrollment Status: Completed
Publish Date: November 15, 2023
Intervention Type: Radiation, Biological
Study Drug: Nivolumab
Study Phase: Phase 2
View 1 Less Clinical Trial

78 Total Publications

Principles of integrative medicine, usefulness and risks of nondrug interventions and complementary therapies
Principles of integrative medicine, usefulness and risks of nondrug interventions and complementary therapies
Journal: La Revue du praticien
Published: June 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Verneuil's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile